Amgen (AMGN) insider buying
14 open-market purchases of AMGN by Amgen's executives and directors since June 2025, worth $0 in total, from SEC Form 4 filings.
The most recent: Maria Elvira Salazar bought — on March 24, 2026.
The biggest buyer over the period is Maria Elvira Salazar: 2 purchases, $0.
By year
| Year | Purchases | Value |
|---|---|---|
| 2026 | 6 | $0 |
| 2025 | 8 | $0 |
Biggest buyers
| Insider | Buys | Value |
|---|---|---|
| Maria Elvira Salazar | 2 | $0 |
| Ro Khanna | 2 | $0 |
| David Taylor | 2 | $0 |
| Marjorie Taylor Greene | 4 | $0 |
| Lisa C. Mcclain | 2 | $0 |
| Cliff Bentz | 2 | $0 |
Every purchase
Newest first. From SEC Form 4 filings. Insider buying across the market.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Mar 24, 2026 | Maria Elvira Salazar |
0 | $348.43 | — | — |
| Mar 24, 2026 | Maria Elvira Salazar |
0 | $348.43 | — | — |
| Feb 24, 2026 | Ro Khanna |
0 | $382.87 | — | — |
| Feb 24, 2026 | Ro Khanna |
0 | $382.87 | — | — |
| Jan 16, 2026 | David Taylor |
0 | $330.41 | — | — |
| Jan 16, 2026 | David Taylor |
0 | $330.41 | — | — |
| Oct 24, 2025 | Marjorie Taylor Greene |
0 | $291.76 | — | — |
| Oct 24, 2025 | Marjorie Taylor Greene |
0 | $291.76 | — | — |
| Sep 11, 2025 | Marjorie Taylor Greene |
0 | $282.73 | — | — |
| Sep 11, 2025 | Marjorie Taylor Greene |
0 | $282.73 | — | — |
| Jun 24, 2025 | Lisa C. Mcclain |
0 | $277.49 | — | — |
| Jun 24, 2025 | Lisa C. Mcclain |
0 | $277.49 | — | — |
| Jun 6, 2025 | Cliff Bentz |
0 | $290.33 | — | — |
| Jun 6, 2025 | Cliff Bentz |
0 | $290.33 | — | — |
Questions
Are Amgen insiders buying the stock?
14 open-market purchases of AMGN by Amgen's executives and directors since June 2025, worth $0 in total, from SEC Form 4 filings. The most recent: Maria Elvira Salazar bought — on March 24, 2026.
What counts as insider buying here?
Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.
From Amgen's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.